Latest updates for Bmc Cancer

Fresh curated links around BMC Cancer are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Metarrestin’s Anti-Cancer Mechanism Mapped Through Network Pharmacology
  • Breast Cancer Brain Metastases Harbor Actionable Genomic Alterations: Could the Brain Lesion Become a Precision-Oncology
  • p53 expression patterns link KAISO and field cancerization in oral cancer

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

bioengineer.org /2 weeks ago

Metarrestin’s Anti-Cancer Mechanism Mapped Through Network Pharmacology

A new network pharmacology study maps how the anti-metastatic drug metarrestin rewires cancer cell protein networks and identifies the cell-cycle regulator CDKN1B as its highest-af...

Read source
letlifehappen.com /1 month ago

Breast Cancer Brain Metastases Harbor Actionable Genomic Alterations: Could the Brain Lesion Become a Precision-Oncology...

From: oncodaily.com Brain metastases remain one of the most difficult complications of metastatic breast cancer. Approximately 30% of patients with metastatic disease will eventual...

Read source
bioengineer.org /1 month ago

p53 expression patterns link KAISO and field cancerization in oral cancer

When the Guardian Loses Its Partner: p53 Surges While KAISO Collapses in Oral Cancer Tissue Deep in the lining of the mouth, one of biology’s most celebrated molecular alliances ap...

Read source
letlifehappen.com /1 month ago

Triple-negative breast cancer: Methylglyoxal at the heart of immune evasion

From: Erurekalert.org A study reveals how methylglyoxal stress – a consequence of cancer cell metabolism – promotes immunosuppression and the formation of metastases, and may contr...

Read source
bioengineer.org /1 week ago

Old Drugs, New Tricks: How Repurposing Could Crack Cancer’s Resistance Problem

A new review in Molecular Cancer maps how approved drugs from outside oncology could be repurposed, under a strict mechanism-first framework, to dismantle the four biological progr...

Read source
bioengineer.org /2 weeks ago

Ten Blood Markers Could Predict Survival in Multiple Myeloma, Study of 812 Patients Finds

Multiple myeloma, an incurable cancer of the bone marrow’s plasma cells, has long defied doctors’ attempts to predict its course. Patients with what looks like the same disease can...

Read source
bioengineer.org /1 month ago

What influences cancer survivors’ participation in colorectal and breast screening

Cancer survivors face a paradox that has long puzzled oncologists and public health researchers alike. Although they belong to one of the highest-risk groups for developing new pri...

Read source
labiotech.eu /3 days ago

B7-H3 ADCs: A new contender in small cell lung cancer and beyond 

Delve into the field of B7-H3 ADCs, a new contender in SCLC cancer as Hansoh Pharma and Medilink bring momentum with positive results. The post B7-H3 ADCs: A new contender in small...

Read source
academyhealth.org /2 weeks ago

AcademyHealth Releases Compendium of Cancer Biomarker Initiatives: A Central Repository for Cancer Biomarker Testing Res...

AcademyHealth Releases Compendium of Cancer Biomarker Initiatives: A Central Repository for Cancer Biomarker Testing Resources AcademyHealth’s Scaling Cancer Biomarker Test...

Read source
qchron.com /3 days ago

ESMO 2026 Preview | Mabwell to Present Clinical Results for Nectin-4-Targeting ADC 9MW2821 in ADC-Pretreated Triple-Nega...

SHANGHAI, Oct. 18, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present Phase II...

Read source
bioengineer.org /1 week ago

Circular RNA Revealed as Hidden Brake on Colorectal Cancer Growth

Researchers report that the circular RNA circMTCL1, sharply depleted in colorectal cancer tumors, suppresses cancer cell growth by sponging miR-145-5p, boosting BMP3, and damping M...

Read source
journals.plos.org /1 month ago

Collagen I promotes cancer cell survival via amino acid import and mTORC1/S6 activation

by Mona Nazemi, Bian Yanes, Eric Vancauwenberghe, Ifeoluwa Oyelade, Heather Walker, Elena Rainero Invasive breast and pancreatic cancer cells thrive within a collagen I-rich, poor...

Read source
journals.plos.org /1 week ago

Genome-Wide DNA methylation profiling of tissue-plasma pairs identifies Novel cfDNA biomarkers for the diagnosis of gast...

by Hailing Ou, Jinli Miao, Fusheng Ling, Jie Gao, Tingan Wang, Zhihua Ye, Chunbo Zhang, Mingwei Huang, Yuzhou Qin Screening for gastric cancer (GC) is critical for improving patie...

Read source
academyhealth.org /1 month ago

AcademyHealth Releases Strategic Roadmap for Advancing Cancer Biomarker Testing at Scale

AcademyHealth Releases Strategic Roadmap for Advancing Cancer Biomarker Testing at Scale For patients facing uncertainty or fear around a cancer diagnosis, cancer biomarker...

Read source
qchron.com /1 day ago

Hengrui Pharma Previews ESMO Congress 2026: 64 Research Findings Highlight Continued Progress Across Innovative Pipeline...

64 research findings have been accepted, including three Proffered Paper presentations and three Rapid Oral presentations, spanning more than ten areas of oncology and supportive c...

Read source
bioengineer.org /1 month ago

Engineered Cytisine Derivative Disrupts Redox Balance to Kill Lung Cancer Cells

Lung cancer continues to claim roughly 1.76 million lives each year, and while chemotherapy has extended survival for many patients, its impact is blunted by severe side effects an...

Read source
letlifehappen.com /1 month ago

Alert-Based ePRO Monitoring Reduces Fatigue in Metastatic Breast Cancer

From: targetedonc.com According to results from the multicenter PRO B trial (German Clinical Trials Register: DRKS00024015), published in JAMA Oncology, weekly electronic patient-r...

Read source
journals.plos.org /1 month ago

Identifying shared polygenic risk across cancers

by Jiaqi Hu, Maiyier Muheyati, Leqi Xu, Andrew DeWan, Hongyu Zhao Background Shared genetic susceptibility across cancers has been reported but is generally modest at the genome-wi...

Read source
bioengineer.org /1 week ago

Mapping the Hidden System That Keeps People With Intellectual Disabilities Out of Cancer Screening

A Dutch team used group model building to map 48 interconnected factors that shape whether people with intellectual disabilities complete cancer screening, revealing decision-makin...

Read source
bioengineer.org /1 month ago

GPSM2 Drives Pancreatic Cancer via m6A-Modified YAP1 mRNA

Pancreatic cancer has long been one of medicine’s most stubborn adversaries, a disease so aggressive and so difficult to detect in its early stages that it is often described as th...

Read source
asianscientist.com /3 weeks ago

This Molecular Switch Helps Triple-Negative Breast Cancers Resist Treatment

Researchers uncover how the long non-coding RNA Smyca helps triple-negative breast cancer cells repair DNA damage and survive treatment.

Read source
bioengineer.org /2 weeks ago

Nerves and Tumours Talk: How the Nervous System Drives Cancer Growth and Drug Resistance

Cancer has long been framed as a disease of rogue genes, a story written almost entirely in the language of mutations, checkpoints and clonal evolution. A new review published in M...

Read source
aacr.org /2 weeks ago

Cancer Today’s Fall 2026 Issue: Activity-based Groups for Survivors, Expanding Treatment Options in Multiple Myeloma, an...

The fall issue of Cancer Today explores treatment advances for people with multiple myeloma whose cancer has returned or stopped responding to treatment, including CAR T-cell thera...

Read source
letlifehappen.com /1 month ago

Genome analysis uncovers candidate genes for hereditary breast and ovarian cancer

By: Inka Burow, Hannover Medical School From: medicalxpress.com Breast cancer is the most common form of cancer among women in Germany: Around 1 in 8 women will develop it during t...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Bmc Cancer

academyhealth.org

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

journals.plos.org

Recent coverage from public sources
Public source

journals.plos.org

Recent coverage from public sources
Public source

aacr.org

Recent coverage from public sources
Public source